Innometry Return On Equity vs. Cash And Equivalents

302430 Stock  KRW 8,020  100.00  1.23%   
Based on the key profitability measurements obtained from Innometry's financial statements, Innometry Co may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Innometry's ability to earn profits and add value for shareholders.
For Innometry profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Innometry to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Innometry Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Innometry's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Innometry Co over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Innometry's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innometry is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innometry's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Innometry Cash And Equivalents vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Innometry's current stock value. Our valuation model uses many indicators to compare Innometry value to that of its competitors to determine the firm's financial worth.
Innometry Co is rated third in return on equity category among its peers. It also is rated third in cash and equivalents category among its peers creating about  1,655,792,503  of Cash And Equivalents per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value Innometry by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Innometry's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Innometry Cash And Equivalents vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Innometry

Return On Equity

 = 

Net Income

Total Equity

 = 
3.0
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Innometry

Cash

 = 

Bank Deposits

+

Liquidities

 = 
4.97 B
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Innometry Cash And Equivalents Comparison

Innometry is currently under evaluation in cash and equivalents category among its peers.

Innometry Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Innometry, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Innometry will eventually generate negative long term returns. The profitability progress is the general direction of Innometry's change in net profit over the period of time. It can combine multiple indicators of Innometry, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Innometry Co., Ltd. manufactures and sells X-ray inspection systems in South Korea. The company was founded in 2008 and is headquartered in Hwaseong, South Korea. INNOMETRY is traded on Korean Securities Dealers Automated Quotations in South Korea.

Innometry Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Innometry. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Innometry position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Innometry's important profitability drivers and their relationship over time.

Use Innometry in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Innometry position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innometry will appreciate offsetting losses from the drop in the long position's value.

Innometry Pair Trading

Innometry Co Pair Trading Analysis

The ability to find closely correlated positions to Innometry could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Innometry when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Innometry - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Innometry Co to buy it.
The correlation of Innometry is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Innometry moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Innometry moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Innometry can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Innometry position

In addition to having Innometry in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Growth Funds Thematic Idea Now

Small Growth Funds
Small Growth Funds Theme
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Innometry Stock

To fully project Innometry's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Innometry at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Innometry's income statement, its balance sheet, and the statement of cash flows.
Potential Innometry investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Innometry investors may work on each financial statement separately, they are all related. The changes in Innometry's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Innometry's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.